04.01.2024
Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Offices
The Netherlands, Gooimeer 2-35 1411 DC Naarden
Germany, Gärtnerplatz 6 80469 München
Number of employees
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Seroba Life Sciences
Seroba is a life sciences venture capital firm investing in breakthrough healthcare technologies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Fountainhead Investment Partners
Fountainhead Investment Partners funds innovation in medical technologies and biologic sciences.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Pontifax
Pontifax is a healthcare-dedicated venture capital firm that finances pharmaceutical and life sciences companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Oxford Bioscience Partners
Oxford Bioscience Partners is a venture capital firm that invests in emerging life sciences and healthcare companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Financials
Investments162
Marea Therapeutics
Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.
total rounds
total raised
Beacon Therapeutics
Beacon Therapeutics is an ophthalmic gene therapy company that restores and improves the vision of patients with retinal diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Bicycle Therapeutics
Bicycle Therapeutics is developing a novel class of medicines.
Sector
Subsector
Location
total rounds
total raised
Co-Investors
Exits68
UniQure
uniQure is a gene therapy company focused on developing treatments for patients suffering from genetic and other devastating diseases.
Sector
Subsector
Location
total rounds
total raised
Acorda Therapeutics
Acorda Therapeutics develops therapies to improve neurological function in nervous system disorders.
Sector
Subsector
Location
total rounds
total raised
Pulmagen Therapeutics
Pulmagen is a drug development company that focuses on creating innovative drugs for chronic respiratory diseases.
Sector
Subsector
Keywords
Location
total rounds
People
Founders1
Sander Slootweg
He currently serves on the boards of Forbion’s portfolio companies Xention Discovery Ltd, Provesica Ltd, Pulmagen Therapeutics, Ltd, Oxyrane Ltd and uniQure. In addition, Sander was responsible for two of Forbion’s recent exits: Biovex, Inc. was sold to Amgen in March of this year for up to USD 1 billion and Fovea Pharmaceutics SA was sold to sanofi-aventis for up to EUR 390 million in 2009. In recent years Sander has served on the boards of Argenta Discovery Ltd (sold to Galapagos in 2010), Alantos Pharmaceuticals, Inc. (sold to Amgen in 2007), Impella Cardiosystems AG (sold to Abiomed, Inc. in 2005), Glycart AG (sold to Roche in 2005), Cambridge Drug Discovery Ltd (sold to Biofocus Plc in 2001), Pieris AG and has acted as the Chairman of the Board of AMT N.V. (Amsterdam, Netherlands / Euronext: AMT). Before co-founding Forbion Capital Partners, he was an Investment Director at ABN AMRO Capital Life Sciences. His other activities at ABN AMRO included buy-out/ growth equities at ABN AMRO Capital, Equity Capital Markets Syndications (HQ Amsterdam) and Financial Institutions Relationship Management Latin America (Regional Office Miami). Sander holds degrees in Business and Financial Economics from the Free University of Amsterdam and Business Administration from Nijenrode University, The Netherlands.
current job
Sander Slootweg
Employee Profiles25
Activity
Recent News20
The graph reveals the ratio (%) of positive news articles in a chosen time range